MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Radiation Dose Management Solution for Clinicians and Patients Released

By MedImaging International staff writers
Posted on 28 Dec 2014
Print article
A new software portal that provides a broad, comprehensive, and holistic radiation dose management strategy for healthcare providers has been released at Radiological Society of North America Annual Meeting (RSNA) 2014.

The software allows providers to keep track of all imaging radiation to which clinicians and patients are exposed. Dose reduction is becoming more important with increasingly stringent dose management compliance standards and regulations such as Medical Imaging & Technology Alliance (MITA) Smart Dose XR-29 standard.

The DoseWise portal allows personal radiation dose tracking, analysis, and monitoring in a range of diagnostic environments and includes training and instructions for safe use of imaging equipment that minimizes cumulative radiation exposure. Improvements in technology are also expected to allow use of reduce radiation doses. The portal includes a number of Philips services and products including IMR, DoseAware, and ClarityIQ.

The portal was developed by Royal Philips (Amsterdam, the Netherlands). According to Gene Saragnese, executive vice president and CEO of Philips Imaging Systems, "Philips DoseWise Solutions return a measure of control to patient care, arming clinicians and informing patients with the tools, training and insights they need in order to ask the right questions regarding radiation dose."

Related Links:

Philips Healthcare


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Ultrasound System
Acclarix AX9
New
Ultrasound System
Voluson Signature 18
DR Flat Panel Detector
1500L

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more